$ Value
$21K
Shares
1,359
Price
$16
Filed
May 19
Insider
Name
Morrison Susan
Title
EVP & Chief Admin. Officer
CIK
0001582970
Roles
Transaction Details
Transaction Date
2025-05-15
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
32,548
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c). | Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. | Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). | Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. | RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. | Awarded on May 25, 2022 pursuant to the 2013 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. | Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). | Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. | Awarded on May 23, 2024 pursuant to the 2023 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Filing Info
Morrison Susan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | TNDM | M | $0 |
| 2026-02-17 | TNDM | F | $10K |
| 2026-02-17 | TNDM | M | $0 |
| 2026-02-17 | TNDM | F | $7K |
| 2026-02-17 | TNDM | M | $0 |
| 2026-02-17 | TNDM | M | $0 |
| 2025-11-17 | TNDM | M | $0 |
| 2025-11-17 | TNDM | F | $8K |
| 2025-11-17 | TNDM | M | $0 |
| 2025-11-17 | TNDM | F | $6K |
Other Insiders at TNDM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sheridan John F
PRESIDENT & CEO
|
— | — | 2026-02-17 |
|
Carpenter Rick
Chief Technology Officer
|
— | — | 2026-02-17 |
|
Morrison Susan
EVP & Chief Admin. Officer
|
— | — | 2026-02-17 |
|
Vosseller Leigh
EVP & CHIEF FINANCIAL OFFICER
|
— | — | 2026-02-17 |
|
Kyrillos Jean-Claude
EVP & Chief Operating Officer
|
— | — | 2026-04-15 |
|
Gasser Elizabeth Anne
EVP, Chief Strategy Officer
|
— | — | 2026-02-17 |
|
Hansen Shannon Marie
EVP & Chief Legal Officer
|
— | — | 2026-02-17 |
|
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
|
— | $4K | 2026-03-17 |